Asset
KER-047
Keros Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05927012 | phase2 | withdrawn | 2023-11-30 | 2025-08-29 | Keros Therapeutics, Inc. | A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia). |
FDA applications (0)
This company has no applications containing this asset.